Presentation TCT 2013 Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR? Presenter: Larry Wood October 29, 2013
Presentation TCT 2013 The Great Debate: Should Diabetes Modulate the PCI vs CABG Equation? Of Course! Thank You for the FREEDOM to Speak Presenter: David Taggart October 29, 2013
Presentation TCT 2013 The Decision to Revascularize Must Be Made on the Background of Improving Medical Therapies and Life Style Modification, with Greater Longevity Presenter: David Maron October 29, 2013
Presentation TCT 2013 PCI vs CABG: A Transparent Analysis of the Current Randomized Trial Data for Different Types of Patients Presenter: Ajay Kirtane October 29, 2013
Presentation TCT 2013 Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transapical TAVR: A Sub-analysis from the PARTNER Trial Presenter: Jean-Michel Paradis October 29, 2013
Presentation TCT 2013 TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV... Presenter: Thierry Lefevre October 29, 2013
Presentation TCT 2013 Left Atrial Appendage Occlusion Devices: Techniques and Different Devices Presenter: Horst Sievert October 29, 2013
Presentation TCT 2013 TCT-119. European Multi-Center Experience with Direct Aortic Transcatheter Aortic Valve Implantation with a Self Expandable Valve Presenter: Giuseppe Bruschi October 29, 2013